207 related articles for article (PubMed ID: 32210304)
1. Lactobacillus reuteri 5454 and Bifidobacterium animalis ssp. lactis 5764 improve colitis while differentially impacting dendritic cells maturation and antimicrobial responses.
Hrdý J; Alard J; Couturier-Maillard A; Boulard O; Boutillier D; Delacre M; Lapadatescu C; Cesaro A; Blanc P; Pot B; Ryffel B; Chamaillard M; Grangette C
Sci Rep; 2020 Mar; 10(1):5345. PubMed ID: 32210304
[TBL] [Abstract][Full Text] [Related]
2. Oral supplementation with selected Lactobacillus acidophilus triggers IL-17-dependent innate defense response, activation of innate lymphoid cells type 3 and improves colitis.
Hrdý J; Couturier-Maillard A; Boutillier D; Lapadatescu C; Blanc P; Procházka J; Pot B; Ryffel B; Grangette C; Chamaillard M
Sci Rep; 2022 Oct; 12(1):17591. PubMed ID: 36266398
[TBL] [Abstract][Full Text] [Related]
3. Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes.
Roselli M; Finamore A; Nuccitelli S; Carnevali P; Brigidi P; Vitali B; Nobili F; Rami R; Garaguso I; Mengheri E
Inflamm Bowel Dis; 2009 Oct; 15(10):1526-36. PubMed ID: 19504616
[TBL] [Abstract][Full Text] [Related]
4. Social stress-enhanced severity of Citrobacter rodentium-induced colitis is CCL2-dependent and attenuated by probiotic Lactobacillus reuteri.
Mackos AR; Galley JD; Eubank TD; Easterling RS; Parry NM; Fox JG; Lyte M; Bailey MT
Mucosal Immunol; 2016 Mar; 9(2):515-26. PubMed ID: 26422754
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulation of dendritic cells by Lactobacillus reuteri surface components and metabolites.
Engevik MA; Ruan W; Esparza M; Fultz R; Shi Z; Engevik KA; Engevik AC; Ihekweazu FD; Visuthranukul C; Venable S; Schady DA; Versalovic J
Physiol Rep; 2021 Jan; 9(2):e14719. PubMed ID: 33463911
[TBL] [Abstract][Full Text] [Related]
6. Histamine H2 Receptor-Mediated Suppression of Intestinal Inflammation by Probiotic Lactobacillus reuteri.
Gao C; Major A; Rendon D; Lugo M; Jackson V; Shi Z; Mori-Akiyama Y; Versalovic J
mBio; 2015 Dec; 6(6):e01358-15. PubMed ID: 26670383
[TBL] [Abstract][Full Text] [Related]
7. Effect of probiotics Lactobacillus acidophilus on Citrobacter rodentium colitis: the role of dendritic cells.
Chen CC; Chiu CH; Lin TY; Shi HN; Walker WA
Pediatr Res; 2009 Feb; 65(2):169-75. PubMed ID: 19262293
[TBL] [Abstract][Full Text] [Related]
8. Probiotics are effective for the prevention and treatment of Citrobacter rodentium-induced colitis in mice.
Rodrigues DM; Sousa AJ; Johnson-Henry KC; Sherman PM; Gareau MG
J Infect Dis; 2012 Jul; 206(1):99-109. PubMed ID: 22430833
[TBL] [Abstract][Full Text] [Related]
9. Probiotic Lactobacillus reuteri attenuates the stressor-enhanced severity of Citrobacter rodentium infection.
Mackos AR; Eubank TD; Parry NM; Bailey MT
Infect Immun; 2013 Sep; 81(9):3253-63. PubMed ID: 23798531
[TBL] [Abstract][Full Text] [Related]
10. Effects of Orally-Administered
Chae JM; Heo W; Cho HT; Lee DH; Kim JH; Rhee MS; Park TS; Kim YK; Lee JH; Kim YJ
J Microbiol Biotechnol; 2018 Nov; 28(11):1800-1805. PubMed ID: 30270609
[TBL] [Abstract][Full Text] [Related]
11. Live and heat-killed probiotic Lactobacillus casei Lbs2 protects from experimental colitis through Toll-like receptor 2-dependent induction of T-regulatory response.
Thakur BK; Saha P; Banik G; Saha DR; Grover S; Batish VK; Das S
Int Immunopharmacol; 2016 Jul; 36():39-50. PubMed ID: 27107798
[TBL] [Abstract][Full Text] [Related]
12. Probiotic mixture supplementation in the preventive management of trinitrobenzenesulfonic acid-induced inflammation in a murine model.
Traina G; Menchetti L; Rappa F; Casagrande-Proietti P; Barbato O; Leonardi L; Carini F; Piro F; Brecchia G
J Biol Regul Homeost Agents; 2016; 30(3):895-901. PubMed ID: 27655518
[TBL] [Abstract][Full Text] [Related]
13. Participation of the intestinal microbiota in the mechanism of beneficial effect of treatment with synbiotic Syngut on experimental colitis under stress conditions.
Konturek PC; Konturek K; Brzozowski T; Wojcik D; Magierowski M; Targosz A; Krzysiek-Maczka G; Sliwowski Z; Strzalka M; Magierowska K; Szczyrk U; Kwiecien S; Ptak-Belowska A; Neurath M; Dieterich W; Wirtz S; Zopf Y
J Physiol Pharmacol; 2020 Jun; 71(3):. PubMed ID: 32991312
[TBL] [Abstract][Full Text] [Related]
14. FolC2-mediated folate metabolism contributes to suppression of inflammation by probiotic Lactobacillus reuteri.
Thomas CM; Saulnier DM; Spinler JK; Hemarajata P; Gao C; Jones SE; Grimm A; Balderas MA; Burstein MD; Morra C; Roeth D; Kalkum M; Versalovic J
Microbiologyopen; 2016 Oct; 5(5):802-818. PubMed ID: 27353144
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide.
Macho Fernandez E; Valenti V; Rockel C; Hermann C; Pot B; Boneca IG; Grangette C
Gut; 2011 Aug; 60(8):1050-9. PubMed ID: 21471573
[TBL] [Abstract][Full Text] [Related]
16. Bifidobacterium longum CCM 7952 Promotes Epithelial Barrier Function and Prevents Acute DSS-Induced Colitis in Strictly Strain-Specific Manner.
Srutkova D; Schwarzer M; Hudcovic T; Zakostelska Z; Drab V; Spanova A; Rittich B; Kozakova H; Schabussova I
PLoS One; 2015; 10(7):e0134050. PubMed ID: 26218526
[TBL] [Abstract][Full Text] [Related]
17. Lactobacillus reuteri-specific immunoregulatory gene rsiR modulates histamine production and immunomodulation by Lactobacillus reuteri.
Hemarajata P; Gao C; Pflughoeft KJ; Thomas CM; Saulnier DM; Spinler JK; Versalovic J
J Bacteriol; 2013 Dec; 195(24):5567-76. PubMed ID: 24123819
[TBL] [Abstract][Full Text] [Related]
18. Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis.
Philippe D; Heupel E; Blum-Sperisen S; Riedel CU
Int J Food Microbiol; 2011 Sep; 149(1):45-9. PubMed ID: 21257218
[TBL] [Abstract][Full Text] [Related]
19. Lactobacillus fermentum ACA-DC 179 displays probiotic potential in vitro and protects against trinitrobenzene sulfonic acid (TNBS)-induced colitis and Salmonella infection in murine models.
Zoumpopoulou G; Foligne B; Christodoulou K; Grangette C; Pot B; Tsakalidou E
Int J Food Microbiol; 2008 Jan; 121(1):18-26. PubMed ID: 18077037
[TBL] [Abstract][Full Text] [Related]
20. New probiotic strains for inflammatory bowel disease management identified by combining in vitro and in vivo approaches.
Alard J; Peucelle V; Boutillier D; Breton J; Kuylle S; Pot B; Holowacz S; Grangette C
Benef Microbes; 2018 Feb; 9(2):317-331. PubMed ID: 29488412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
